Gue Ying X, Gorog Diana A
Department of Cardiology, East and North Hertfordshire NHS Trust, Hertfordshire SG1 4AB, UK.
Department of Postgraduate Medicine, University of Hertfordshire, Hertfordshire AL10 9AB, UK.
Int J Mol Sci. 2017 Aug 25;18(9):1850. doi: 10.3390/ijms18091850.
The processes of thrombosis and coagulation are finely regulated by endogenous fibrinolysis maintaining healthy equilibrium. When the balance is altered in favour of platelet activation and/or coagulation, or if endogenous fibrinolysis becomes less efficient, pathological thrombosis can occur. Arterial thrombosis remains a major cause of morbidity and mortality in the world despite advances in medical therapies. The role endogenous fibrinolysis in the pathogenesis of arterial thrombosis has gained increasing attention in recent years as it presents novel ways to prevent and treat existing diseases. In this review article, we discuss the role of endogenous fibrinolysis in platelet thrombus formation, methods of measurement of fibrinolytic activity, its role in predicting cardiovascular diseases and clinical outcomes and future directions.
血栓形成和凝血过程受到内源性纤维蛋白溶解的精细调节,以维持健康的平衡。当平衡向有利于血小板活化和/或凝血的方向改变时,或者如果内源性纤维蛋白溶解效率降低,就会发生病理性血栓形成。尽管医学治疗取得了进展,但动脉血栓形成仍然是全球发病和死亡的主要原因。近年来,内源性纤维蛋白溶解在动脉血栓形成发病机制中的作用越来越受到关注,因为它为预防和治疗现有疾病提供了新的途径。在这篇综述文章中,我们讨论了内源性纤维蛋白溶解在血小板血栓形成中的作用、纤维蛋白溶解活性的测量方法、其在预测心血管疾病和临床结果中的作用以及未来的方向。